Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AV7909 (CYFENDUS) Anthrax Vaccine in Healthy Adults
NCT05997264Phase 2Completed
- Sponsor
- Biomedical Advanced Research and Development Authority
- Start
- Dec 2023
- Primary completion
- Aug 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of anthrax vaccine adsorbed in anthrax, sponsored by Biomedical Advanced Research and Development Authority. Started Dec 2023; status: completed.
02
Drugs
anthrax vaccine adsorbed
03
Conditions
anthrax
Beyond the preview
Go deeper on NCT05997264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05997264.